ITC: Apple's redesigned blood oxygen feature doesn't infringe Masimo patents
10 hours ago
- #HealthTech
- #Apple
- #Legal
- An ITC Administrative Law Judge found that Apple's redesigned Apple Watch blood oxygen feature does not infringe on Masimo's patents.
- The Federal Circuit upheld the ITC's initial exclusion order, keeping the original blood oxygen feature banned in the U.S.
- Apple's redesigned feature shifts most processing to the iPhone, requiring users to view results on their iPhone rather than the Watch.
- The ITC Commission will review the initial determination for a final decision.
- Apple praised the judge's decision, stating Masimo's claims have largely been rejected over six years.
- The Federal Circuit's decision maintains the ban on the original blood oxygen feature, but Apple can still sell Watches with the redesigned feature.
- Apple disagrees with the Federal Circuit's ruling and is exploring further review options.